Germany's Draegerwerk Q1 EBIT rises on higher sales

Draegerwerk AG & Co KGaA

16/04/2026 18:29

Overview

Germany medical and safety equipment maker's preliminary Q1 net sales rose 6.9% yr/yr (net of currency effects; nominal: 3.5%)

Preliminary Q1 EBIT increased sharply, driven by higher sales and improved gross margin

Company maintained full-year forecast for net sales and EBIT margin growth

Outlook

Drägerwerk expects 2026 net sales to rise 1.0% to 5.0%

Company sees 2026 EBIT margin between 5.0% and 7.5%

Result Drivers

SALES GROWTH - Higher net sales in both medical and safety divisions contributed to improved earnings

GROSS MARGIN - Improved gross margin supported higher EBIT

LOWER FUNCTIONAL EXPENSES - Decrease in functional expenses, partly due to a one-off payment for employees in the prior year, aided results

Company press release: ID:nEQ9X6PfFa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EBIT
EUR 18 mln
Q1 EBIT Margin
2.40%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Draegerwerk AG & Co KGaA is €92.00, about 22.7% above its April 16 closing price of €75.00

The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)